Navigation Links


Fite at Biology News

Fite at Biology Products

EpiTect Bisulfite Kit from QIAGEN

Description:The EpiTect Bisulfite Kit enables complete conversion of unmethylated cytosines to uracils in less than 6 hours. The highly sensitive method utilizes an innovative protection against DNA degradation and a spin-column-based purification and desulfonation procedure to guarantee fast and reliable results for all downstream applications. The EpiTect Bisulfite Kit complements QIAGENs range of DNA clea...
Company:QIAGEN

Methlation Analysis/Bisulfite Sequencing from Seqwright

Description:Methylation analysis of gene promoters using bilsulfite treatment of DNA and comparative DNA sequence analysis. Probe design and PCR included....
Company:Seqwright
Fite at Biology Technology
Fite at Medicine News

Children Benefited By Moderate Maternal Stress?

Disputing the widely held belief, moderate levels of psychological stress in the expectant mother might prove beneficial to fetal maturation,// according to research conducted at the Johns Hopkins University and the National Institute of Child Health and Human Development. The study is published in the May/June 2006 edition of the journal Child Development. "We found that modest anxiety...

Older Adults could be Benefited from Chinese Martial-Arts

Ancient Chinese exercises, which focus on meditation and relaxation techniques, have proved beneficial for older adults – a new study by researchers at the University of Illinois says//. Adding strength to the previous work, a recent study of Martial arts such as Qigong and Taiji, practiced by ancient Chinese showed potential health benefits to older adults. Qigong (chee-kung)...

Engineered Tissue Implants benefited Knee Injured patients

Scientists at the University of Bristol have recommended that knee cartilage injuries could be possibly repaired by bioengineered tissue implants //without any signs of osteoarthritis progression. 'The maturation of cartilage implanted with engineered tissue has taken only about 12 months and this is the first of its kind to study' – researchers reports. The study, 'Maturatio...

Preterm Babies Benefited from a New NI Spectroscopy

Researchers at the Monash Institute of Medical Research (MIMR) have developed a new machine, named near-infrared spectroscopy, which allowed scientists// to monitor preterm babies constantly. Although it was the first of its kind in Australia, helped doctors to monitor continuously, the fluctuating BP and brain oxygen levels of a preterm babies. Scientists at the Monash Inst...

Physical Activity benefited Peripheral Artery Disease (PAD) patients

According to a comparative study, physically active peripheral artery disease (PAD) patients have showed lesser death rates than PAD patients who are physically inactive//. Researchers have also indicated that less physically active PAD patients had an increased risk for heart diseases. ‘We found that there is a survival benefit for patients with PAD who are more physically ac...

More>>

Fite at Medicine Products
Fite at Medicine Technology

Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology

PETACH TIKVA, Israel--(BUSINESS WIRE)--Jun 14, 2007 - Can-FiteBioPharma (TASE:CFBI), a biotechnology company traded on the TelAviv Stock Exchange Exchange, proceeds with the development of itsthird drug CF502; this is in addition to CF101, which is currentlyin clinical trials and CF102, which is in preclinical phases. Thisweekend Can-Fite will present at the EUALR annual congress ofrheumato...

Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine

OSLO, Norway--(BUSINESS WIRE)--Apr 23, 2007 - Affitech AS, thehuman antibody therapeutics company announced today that PeregrinePharmaceuticals, Inc. reported positive in vivo test results of R3,a fully human monoclonal antibody developed by Affitech, in apancreatic cancer model at the recently concluded Centennial AnnualMeeting of the American Association for Cancer Research (AACR). R3has...
Other TagsAngledAngledSutureTennantJaffeTyingSheets
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
(Date:8/28/2008)... NEW YORK (AUGUST 28, 2008) A WCS repor...obally threatened primates in a protected area in ...anked douc langurs along with 2,500 yellow-cheeked...Conservation Area, an estimate that represents the... world., , WCS scientists conducted the surveys...
(Date:8/28/2008)...archers at The University of Nottingham have devel...s to look at microscopic activity within the body,...e, live as it happens. , The cutting edge laser ...the MRC (Medical Research Council) for a five-year...ny world of activity taking place within single ce...
(Date:8/28/2008)... Journal of Nutrition, Health and Aging publishes...nteraction between nutrition and health in the agi... latest scientific findings on the fundamental imp...span. The journal is published ten times a year in..., "The partnership with Springer from 2009 shoul...
(Date:8/27/2008)...ting in Nature Genetics, and working in conjunct...stered fund that is dedicated to exploring new ave...ty, scientist Robert Hoffmann, has developed the f...n a powerful authorship tracking technology, this ...sponding author. In this way readers can always kn...
Breaking Biology News(10 mins):Unexpected large monkey population discovered 2Life under the laser 2ETH Zurich-administered fund ends scientific anonymity 2Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital 3176 1Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital 3176 2Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 1Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 2Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 3AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 1AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 2AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 3AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 4American Chemical Societys Weekly PressPac Feb 6 2008 11486 1American Chemical Societys Weekly PressPac Feb 6 2008 11486 2American Chemical Societys Weekly PressPac Feb 6 2008 11486 3American Chemical Societys Weekly PressPac Feb 6 2008 11486 4American Chemical Societys Weekly PressPac Feb 6 2008 11486 5American Chemical Societys Weekly PressPac Feb 6 2008 11486 6American Chemical Societys Weekly PressPac Feb 6 2008 11486 7American Chemical Societys Weekly PressPac Feb 6 2008 11486 8American Chemical Societys Weekly PressPac Feb 6 2008 11486 9
Other Contentshormonehormonehormonehormonehormonehormonehormonehormonehormoneprojectprojectprojectprojectprojectprojectprojectprojectprojectgenomegenomegenomegenomegenomegenomegenomegenomehumanhumanhumanhumanhumanhumanhumanhumanhumanhumanhydrolysishydrolysishydrolysishydrolysishydrolysishydrolytic